查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026750

心臟衰竭即時檢測 (POC) 和局部檢測 (LOC) 設備市場預測至 2034 年——按檢測類型、技術、最終用戶和地區分類的全球分析

Heart Failure POC And LOC Devices Market Forecasts to 2034 - Global Analysis By Test Type, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球用於心臟衰竭的即時檢測和線下檢測設備的市場規模將達到 1.641 億美元，在預測期內以 18.9% 的複合年成長率成長，到 2034 年將達到 6.554 億美元。

即時診斷（POC）和晶片實驗室（LOC）設備在心臟衰竭治療領域具有革命性意義。這些攜帶式快速診斷技術使醫護人員能夠進行現場檢測，並即時了解患者​​的心臟健康狀況。可在患者床邊和基層醫療機構進行快速有效診斷的POC設備包括攜帶式超音波診斷設備、攜帶式心臟生物標記分析儀和微型晶片實驗室平台。

根據美國疾病管制與預防中心 (CDC) 2018 年的報告，每年約有 655,000 名美國人死於心臟病，使其成為美國的主要死因（佔死亡總數的四分之一）。

心臟衰竭衰竭發生率不斷上升

即時檢測（POC​​）和遠端檢測（LOC）設備市場的主要驅動力是心臟衰竭發生率的上升。這與人口老化、久坐的生活方式以及心血管疾病風險因素負擔的加重密切相關。此外，全球心臟衰竭盛行率的不斷攀升也促使人們對能夠快速、準確評估心臟功能並支持快速高效治療方案製定的診斷設備的需求日益成長。

預算限制和可及性

與即時檢測（POC​​）和遠端檢測（LOC）設備相關的財務限制不僅包括初始部署成本，還包括耗材、維護和校準等持續性費用。此外，患者和醫療機構都專注於成本效益，尤其是在資源有限的環境中。這些先進診斷工具的高昂初始成本可能會阻礙其廣泛應用，限制其可用性，並影響醫療服務的成本效益。

擴展診斷能力

即時檢測（POC​​）和晶片檢測（LOC）設備的診斷能力仍有許多提升空間。尤其是在生物感測器、微流體和奈米技術等領域，持續的技術進步可望提高這些設備的靈敏度和特異性。此外，多重檢測技術的進步以及新型生物標記的整合，能夠幫助醫療專業人員更深入、更全面地了解心血管健康狀況。

激烈的市場競爭

POC及LOC設備市場競爭異常激烈，面臨價格壓力、市場飽和、產品差異化困難等風險。新參與企業和持續的技術進步進一步加劇了競爭。為了保持競爭力，企業必須加強研發投入，實施有效的行銷策略，並專注於開發獨特的價值提案，以鞏固市場地位並實現持續成長。

新冠疫情的影響：

新冠疫情對醫療診斷市場產生了重大影響，尤其是即時檢測（POC​​）和晶片實驗室（LOC）設備市場。由於對快速、分散式檢測解決方案的需求激增，POC和LOC設備的需求也隨之飆升，尤其是在新冠肺炎診斷方面。這些技術進步在改善檢測可及性和實現臨床環境中快速出具檢測結果方面發揮了關鍵作用。然而，疫情也帶來了許多挑戰，例如醫療資源分配的變化、競爭加劇以及供應鏈中斷。此外，應對疫情也促進了創新，並凸顯了POC和LOC設備在靈活分散式醫療系統中發揮的關鍵作用。這很可能影響後疫情時代市場的未來發展方向。

在預測期內，基因組檢測領域預計將成為規模最大的領域。

在心臟衰竭即時檢測（POC​​）和遠端檢測（LOC）設備市場中，基因組檢測預計將佔據最大的市場佔有率。基因組檢測透過分析個體的DNA來識別基因變異、突變和疾病易感性。由於其在藥物基因體學、腫瘤學、罕見遺傳疾病和個人化醫療等領域的廣泛應用，該領域正日益受到重視。基因組檢測對於疾病的診斷、治療和風險評估至關重要，能夠實現更專業、更有效率的醫療介入。此外，隨著定序技術的不斷進步和對各種疾病遺傳因素認知的不斷積累，基因組檢測的應用日益普及，並被認為是分子診斷領域的重要組成部分。

在預測期內，居家照護領域預計將呈現最高的複合年成長率。

在心臟衰竭即時檢測（POC​​）和遠距醫療（LOC）設備市場中，居家照護細分市場以最高的複合年成長率成長。接受居家照護服務的患者可以在舒適的家中接受醫療照護、監測和支援。人口老化、對個人化和以患者為中心的護理的需求以及遠端監測技術的進步等諸多因素，都促成了居家照護需求的成長。居家照護服務不僅為病患帶來便利，還能透過減少住院時間來降低醫療成本。此外，新冠疫情加速了居家照護服務的普及，因為疫情使得人們對風險較低的離線就診替代方案的需求日益成長。

市佔率最大的地區：

預計北美將在心臟衰竭檢測（POC​​）和線下檢測（LOC）設備市場佔據最大的市場佔有率。這主要歸功於其高昂的醫療費用支出、先進的醫療基礎設施、健全的監管體係以及對研發的高度重視。特別是美國，憑藉其龐大的醫療保健產業，是支撐該地區市場主導地位的重要因素。此外，北美在醫療保健普及、技術創新以及應對人口老化問題方面也表現出色。

複合年成長率最高的地區：

亞太地區心臟衰竭即時檢測（POC​​）和遠距醫療（LOC）設備市場正以最高的複合年成長率成長。醫療保健意識的提高、可支配收入的增加、醫療基礎設施的不斷完善以及大規模的老齡人口是推動這一爆炸式成長的部分因素。中國和印度等亞太國家正在加大對醫療服務和技術的政府投資。此外，對尖端醫療技術的需求以及慢性病發病率的上升也支撐著亞太地區醫療保健市場的強勁成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球心臟衰竭即時檢測 (POC) 和遠端檢測 (LOC) 設備市場：按檢測類型分類

  • 蛋白質體學檢測
  • 代謝體學學檢測
  • 基因組檢測
  • 其他測試類型

第6章 全球心臟衰竭即時偵測與線下偵測設備市場：依技術分類

  • 微流體技術
  • 基於陣列的系統
  • 其他技術

第7章 全球心臟衰竭即時偵測與線下偵測設備市場：依最終用戶分類

  • 診所和醫院
  • 居家照護
  • 輔助生活醫療保健設施
  • 檢查室
  • 專業醫療中心
  • 其他最終用戶

第8章 全球心臟衰竭即時偵測與線下偵測設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第9章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第10章：公司簡介

  • Instrumentation Laboratory Company
  • F. Hoffmann-La Roche Ltd
  • Abaxis, Inc.
  • Jant Pharmacal Corporation
  • Danaher Corporation
  • Siemens Healthineers
  • Trinity Biotech
  • Quidel Corporation
  • Abbott
  • bioMerieux SA
Product Code: SMRC24750

According to Stratistics MRC, the Global Heart Failure POC and LOC Devices Market is accounted for $164.1 million in 2026 and is expected to reach $655.4 million by 2034 growing at a CAGR of 18.9% during the forecast period. Devices known as point-of-care (POC) and lab-on-a-chip (LOC) have become revolutionary in the treatment of heart failure. Healthcare providers can perform on-the-spot testing with these portable, rapid diagnostic technologies, giving them quick insights into a patient's cardiac health. POC devices, which provide quick and effective diagnostics at the patient's bedside or in primary care settings, include handheld ultrasound devices, portable cardiac biomarker analyzers, and miniaturized lab-on-a-chip platforms.

According to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths).

Market Dynamics:

Driver:

Growing heart failure rates

The market for POC and LOC devices is primarily driven by the rising incidence of heart failure, which is linked to aging populations, sedentary lifestyles, and the mounting burden of cardiovascular risk factors. Additionally, globally, the prevalence of heart failure is increasing, which raises the need for diagnostic instruments that can quickly and accurately evaluate cardiac function and support prompt and efficient treatment plans.

Restraint:

Budgetary restrictions and accessibility

The financial limitations pertaining to POC and LOC devices comprise not only the initial acquisition costs but also continuous expenditures like consumables, maintenance, and calibration. Furthermore, patients and healthcare facilities alike are concerned about affordability, especially in environments with limited resources. These advanced diagnostic tools come with a high upfront cost, which could prevent them from being widely adopted, restrict accessibility, and affect how cost-effectively healthcare is delivered.

Opportunity:

Extension of diagnostic expertise

There are numerous opportunities to increase the diagnostic capabilities that POC and LOC devices offer. Sustained technological progress, specifically in domains like biosensors, micro fluidics, and nanotechnology, offers prospects for augmenting the sensitivity and specificity of said apparatus. Moreover, healthcare practitioners can now obtain a deeper and more comprehensive understanding of cardiovascular health thanks to advancements in multiplexed testing and the integration of novel biomarkers.

Threat:

Strong market rivalry

The POC and LOC device market is highly competitive, which poses risks like price pressure, market saturation, and difficulty differentiating products. The pressure to compete is increased by new entrants and ongoing technological advancements. Furthermore, in order to stay competitive, businesses need to make investments in R&D, put effective marketing strategies into practice, and concentrate on developing distinctive value propositions in order to hold onto their market positions and continue growing.

Covid-19 Impact:

The COVID-19 pandemic has had a significant effect on the market for medical diagnostics, particularly point-of-care (POC) and lab-on-a-chip (LOC) devices. Demand for POC and LOC devices has surged due to the pressing need for quick and decentralized testing solutions, especially in the diagnosis of COVID-19. These technological advancements have been essential in improving test accessibility and facilitating prompt results at the point of care. On the other hand, the pandemic has also brought about difficulties like changes in the distribution of healthcare resources, heightened competition, and supply chain disruptions. Moreover, the management of the pandemic has spurred innovation and highlighted the critical role POC and LOC devices play in flexible, decentralized healthcare systems, which will impact the market's future direction in the aftermath of the pandemic.

The Genomic Testing segment is expected to be the largest during the forecast period

The segment of the heart failure POC and LOC devices market that is expected to hold the largest share is genomic testing. A person's DNA is analyzed as part of a genomic test to find genetic variants, mutations, and disease predispositions. The broad applications of this segment in pharmacogenomics, oncology, rare genetic disorders, and personalized medicine have made it more well-known. In order to diagnose, treat, and evaluate disease risk, genomic testing is essential. This results in more specialized and efficient healthcare interventions. Additionally, genomic testing is becoming increasingly popular and is becoming recognized as a major player in the field of molecular diagnostics due to the ongoing improvements in sequencing technologies and the growing knowledge of the genetic causes of various diseases.

The Home Care segment is expected to have the highest CAGR during the forecast period

In the market for heart failure POC and LOC devices, the home care segment is growing at the highest CAGR. Patients receiving home care services receive medical attention, supervision, and support in the comfort of their own homes. A number of factors, such as an aging population, a desire for individualized and patient-centered care, and developments in remote monitoring technologies, have contributed to the rise in demand for home care. In addition to providing patients with convenience, home care services lower healthcare costs by minimizing hospital stays. Moreover, the COVID-19 pandemic has expedited the uptake of home care services as individuals pursue less hazardous substitutes for in-person medical consultations.

Region with largest share:

It is projected that the heart failure POC and LOC device market will have the largest share in the North American region. This is ascribed to elements like high healthcare spending, sophisticated healthcare infrastructure, a solid regulatory base, and a strong emphasis on R&D. With a large healthcare industry footprint, the United States in particular is a major factor contributing to the region's dominance. Furthermore, North America gains from a focus on healthcare accessibility, technological innovation, and an aging population.

Region with highest CAGR:

The market for heart failure POC and LOC devices is growing at the highest CAGR in the Asia-Pacific region. Growing healthcare awareness, rising disposable incomes, growing healthcare infrastructure, and an aging and sizable population are some of the factors driving this explosive growth. Significant investments in healthcare services and technology are being made in APAC nations like China and India, along with encouraging government initiatives. Additionally, the demand for cutting-edge medical treatments and the rising incidence of chronic diseases both support the strong growth in the Asia-Pacific healthcare market.

Key players in the market

Some of the key players in Heart Failure POC and LOC Devices market include Instrumentation Laboratory Company, F. Hoffmann-La Roche Ltd, Abaxis, Inc., Jant Pharmacal Corporation, Danaher Corporation, Siemens Healthineers, Trinity Biotech, Quidel Corporation, Abbott and bioMerieux S.A.

Key Developments:

In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.

In December 2023, Danaher Corp., a global life sciences and diagnostics provider based in Washington D.C., has completed its $5.7 billion acquisition of Abcam plc, a supplier of protein research tools for life sciences based in Cambridge, England. Abcam has become an indirect wholly owned subsidiary of Danaher. Danaher's Life Sciences businesses provide tools and technologies to support the advancement of pharmaceuticals and biopharmaceuticals.

In November 2023, Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

Test Types Covered:

  • Proteomic Testing
  • Metabolomic Testing
  • Genomic Testing
  • Other Test Types

Technologies Covered:

  • Microfluidics
  • Array-based Systems
  • Other Technologies

End Users Covered:

  • Clinics & Hospitals
  • Home Care
  • Assisted Living Healthcare Facilities
  • Laboratory
  • Specialty Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Heart Failure POC And LOC Devices Market, By Test Type

  • 5.1 Introduction
  • 5.2 Proteomic Testing
  • 5.3 Metabolomic Testing
  • 5.4 Genomic Testing
  • 5.5 Other Test Types

6 Global Heart Failure POC And LOC Devices Market, By Technology

  • 6.1 Introduction
  • 6.2 Microfluidics
  • 6.3 Array-based Systems
  • 6.4 Other Technologies

7 Global Heart Failure POC And LOC Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Clinics & Hospitals
  • 7.3 Home Care
  • 7.4 Assisted Living Healthcare Facilities
  • 7.5 Laboratory
  • 7.6 Specialty Centers
  • 7.7 Other End Users

8 Global Heart Failure POC And LOC Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Instrumentation Laboratory Company
  • 10.2 F. Hoffmann-La Roche Ltd
  • 10.3 Abaxis, Inc.
  • 10.4 Jant Pharmacal Corporation
  • 10.5 Danaher Corporation
  • 10.6 Siemens Healthineers
  • 10.7 Trinity Biotech
  • 10.8 Quidel Corporation
  • 10.9 Abbott
  • 10.10 bioMerieux S.A

List of Tables

  • Table 1 Global Heart Failure POC And LOC Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Heart Failure POC And LOC Devices Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 3 Global Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2023-2034) ($MN)
  • Table 4 Global Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2023-2034) ($MN)
  • Table 5 Global Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2023-2034) ($MN)
  • Table 6 Global Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 7 Global Heart Failure POC And LOC Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 8 Global Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 9 Global Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2023-2034) ($MN)
  • Table 10 Global Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 11 Global Heart Failure POC And LOC Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 12 Global Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2023-2034) ($MN)
  • Table 13 Global Heart Failure POC And LOC Devices Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 14 Global Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2023-2034) ($MN)
  • Table 15 Global Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2023-2034) ($MN)
  • Table 16 Global Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 17 Global Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 18 North America Heart Failure POC And LOC Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 19 North America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 20 North America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2023-2034) ($MN)
  • Table 21 North America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2023-2034) ($MN)
  • Table 22 North America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2023-2034) ($MN)
  • Table 23 North America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 24 North America Heart Failure POC And LOC Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 25 North America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 26 North America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2023-2034) ($MN)
  • Table 27 North America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 28 North America Heart Failure POC And LOC Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 29 North America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2023-2034) ($MN)
  • Table 30 North America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 31 North America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2023-2034) ($MN)
  • Table 32 North America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2023-2034) ($MN)
  • Table 33 North America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 34 North America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 35 Europe Heart Failure POC And LOC Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 36 Europe Heart Failure POC And LOC Devices Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 37 Europe Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2023-2034) ($MN)
  • Table 38 Europe Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2023-2034) ($MN)
  • Table 39 Europe Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2023-2034) ($MN)
  • Table 40 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 41 Europe Heart Failure POC And LOC Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 42 Europe Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 43 Europe Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2023-2034) ($MN)
  • Table 44 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 45 Europe Heart Failure POC And LOC Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 46 Europe Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2023-2034) ($MN)
  • Table 47 Europe Heart Failure POC And LOC Devices Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 48 Europe Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2023-2034) ($MN)
  • Table 49 Europe Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2023-2034) ($MN)
  • Table 50 Europe Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 51 Europe Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 52 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 53 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 54 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2023-2034) ($MN)
  • Table 55 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2023-2034) ($MN)
  • Table 56 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2023-2034) ($MN)
  • Table 57 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 58 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 59 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 60 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2023-2034) ($MN)
  • Table 61 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 62 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 63 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2023-2034) ($MN)
  • Table 64 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 65 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2023-2034) ($MN)
  • Table 66 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2023-2034) ($MN)
  • Table 67 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 68 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 69 South America Heart Failure POC And LOC Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 70 South America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 71 South America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2023-2034) ($MN)
  • Table 72 South America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2023-2034) ($MN)
  • Table 73 South America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2023-2034) ($MN)
  • Table 74 South America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 75 South America Heart Failure POC And LOC Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 76 South America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 77 South America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2023-2034) ($MN)
  • Table 78 South America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 79 South America Heart Failure POC And LOC Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 80 South America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2023-2034) ($MN)
  • Table 81 South America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 82 South America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2023-2034) ($MN)
  • Table 83 South America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2023-2034) ($MN)
  • Table 84 South America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 85 South America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 86 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Country (2023-2034) ($MN)
  • Table 87 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 88 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2023-2034) ($MN)
  • Table 89 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2023-2034) ($MN)
  • Table 90 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2023-2034) ($MN)
  • Table 91 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 92 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 93 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2023-2034) ($MN)
  • Table 94 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2023-2034) ($MN)
  • Table 95 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 96 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 97 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2023-2034) ($MN)
  • Table 98 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Home Care (2023-2034) ($MN)
  • Table 99 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2023-2034) ($MN)
  • Table 100 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2023-2034) ($MN)
  • Table 101 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2023-2034) ($MN)
  • Table 102 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2023-2034) ($MN)